{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:35:55Z","timestamp":1791228955050,"version":"4.1.0"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["26\\u201315-20006"],"award-info":[{"award-number":["26\\u201315-20006"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejpb.2026.115183","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:07:56Z","timestamp":1783922876000},"page":"115183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advanced delivery systems for sodium thiosulfate in cisplatin otoprotection"],"prefix":"10.1016","volume":"227","author":[{"given":"Natallia V.","family":"Dubashynskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey Y.","family":"Borovskoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5960-068X","authenticated-orcid":false,"given":"Sergei G.","family":"Zhuravskii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9731-6399","authenticated-orcid":false,"given":"Yury A.","family":"Skorik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115183_b0005","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/cancers12051266","article-title":"Assessment and management of platinum-related ototoxicity in children treated for cancer","volume":"12","author":"Romano","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejpb.2026.115183_b0010","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/pbc.26165","article-title":"Pediatric malignant germ cell tumors: a comparison of the neuro\u2010oncology and solid tumor experience","volume":"63","author":"Plant","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejpb.2026.115183_b0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: new insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejpb.2026.115183_b0020","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00467-023-06149-9","article-title":"Long-term cisplatin nephrotoxicity after childhood cancer: a systematic review and meta-analysis","volume":"39","author":"Schofield","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejpb.2026.115183_b0025","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.3390\/ijms24087585","article-title":"Cisplatin in ovarian cancer treatment\u2014known limitations in therapy force new solutions","volume":"24","author":"Zo\u0144","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/AUD.0000000000001119","article-title":"Evaluating the efficacy of intratympanic dexamethasone in protecting against irreversible hearing loss in patients on cisplatin-based cancer treatment: a randomized controlled phase IIIB clinical trial","volume":"43","author":"Moreno","year":"2022","journal-title":"Ear Hear."},{"key":"10.1016\/j.ejpb.2026.115183_b0035","doi-asserted-by":"crossref","first-page":"16545","DOI":"10.3390\/ijms242216545","article-title":"Molecular characteristics of cisplatin-induced ototoxicity and therapeutic interventions","volume":"24","author":"Tan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0040","first-page":"274","article-title":"Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional north American cohort study, the Lancet Child & Adolescent","volume":"5","author":"Moke","year":"2021","journal-title":"Health"},{"key":"10.1016\/j.ejpb.2026.115183_b0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cncr.33848","article-title":"The cumulative incidence of cisplatin\u2010induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments","volume":"128","author":"Meijer","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.ejpb.2026.115183_b0050","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.2147\/DDDT.S212313","article-title":"The role of the reactive oxygen species scavenger agent, astaxanthin, in the protection of cisplatin-treated patients against hearing loss","author":"Nan","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejpb.2026.115183_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2020.110401","article-title":"Ototoxicity-induced hearing loss and quality of life in survivors of paediatric cancer","volume":"138","author":"Rajput","year":"2020","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.ejpb.2026.115183_b0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejpb.2021.03.008","article-title":"Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies","volume":"163","author":"Tang","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115183_b0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1470-2045(16)30625-8","article-title":"Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial","volume":"18","author":"Freyer","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejpb.2026.115183_b0070","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1470-2045(22)00155-3","article-title":"Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431","volume":"23","author":"Orgel","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejpb.2026.115183_b0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jinorgbio.2016.06.012","article-title":"Chemical basis for the detoxification of cisplatin-derived hydrolysis products by sodium thiosulfate","volume":"162","author":"Sooriyaarachchi","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejpb.2026.115183_b0080","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1200\/JCO.24.00905","article-title":"Randomized phase Ib clinical trial of DB-020 intratympanic injections to reduce high-dose cisplatin ototoxicity","volume":"43","author":"Panizza","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2026.115183_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1336714","article-title":"Prevention of cisplatin-induced hearing loss in children: achievements and challenges for evidence-based implementation of sodium Thiosulfate","volume":"14","author":"Meijer","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejpb.2026.115183_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31631","article-title":"Real\u2010world experience using sodium thiosulfate pentahydrate off\u2010label for cisplatin otoprotection in children, adolescents, and young adults","volume":"72","author":"Ma","year":"2025","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejpb.2026.115183_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcped.2024.100211","article-title":"Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients\u2013a narrative literature review to explore the potential benefit for children with cancer","volume":"5","author":"Streefkerk","year":"2025","journal-title":"EJC Paediatric Oncology"},{"key":"10.1016\/j.ejpb.2026.115183_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.107955","article-title":"Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients\u2013a retrospective analysis","volume":"50","author":"Vachez","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ejpb.2026.115183_b0105","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2611464","article-title":"Advances in the clinical applications of sodium thiosulphate","volume":"58","author":"Deng","year":"2026","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejpb.2026.115183_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40463-019-0327-x","article-title":"A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer","volume":"48","author":"Rolland","year":"2019","journal-title":"Journal of Otolaryngology-Head & Neck Surgery"},{"key":"10.1016\/j.ejpb.2026.115183_b0115","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410568","article-title":"Rational design of inner ear drug delivery systems","volume":"12","author":"Maimaitikelimu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fncel.2019.00300","article-title":"Local drug delivery for prevention of hearing loss","volume":"13","author":"Rybak","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/00016488809125107","article-title":"Barrier systems in the inner ear","volume":"105","author":"Juhn","year":"1988","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ejpb.2026.115183_b0130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/pharmaceutics17040482","article-title":"The blood-labyrinth barrier: non-invasive delivery strategies for inner ear drug delivery","volume":"17","author":"Yi","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115183_b0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.heares.2016.12.012","article-title":"Culture media-based selection of endothelial cells, pericytes, and perivascular-resident macrophage-like melanocytes from the young mouse vestibular system","volume":"345","author":"Zhang","year":"2017","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.heares.2016.01.010","article-title":"Pathophysiology of the cochlear intrastrial fluid-blood barrier","volume":"338","author":"Shi","year":"2016","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00016488809138882","article-title":"Structure of the round window membrane","volume":"105","author":"Hellstr\u00f6m","year":"1988","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ejpb.2026.115183_b0150","doi-asserted-by":"crossref","first-page":"E598","DOI":"10.1002\/lary.28738","article-title":"Anatomy of the round window region with relation to selection of entry site into the scala tympani","volume":"131","author":"Pringle","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejpb.2026.115183_b0155","volume":"11","author":"Nyberg","year":"2019","journal-title":"Delivery of Therapeutics to the Inner Ear: the Challenge of the Blood-Labyrinth Barrier, Science Translational Medicine"},{"key":"10.1016\/j.ejpb.2026.115183_b0160","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/ph15091105","article-title":"Development and characterization of an in vitro round window membrane model for drug permeability evaluations","volume":"15","author":"Singh","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2026.115183_b0165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115183_b0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/toxics3030268","article-title":"Cisplatin-induced ototoxicity: effects, mechanisms and protection strategies","volume":"3","author":"Callejo","year":"2015","journal-title":"Toxics"},{"key":"10.1016\/j.ejpb.2026.115183_b0175","doi-asserted-by":"crossref","first-page":"e2731","DOI":"10.1002\/jmr.2731","article-title":"Analysis of single, cisplatin\u2010induced DNA bends by atomic force microscopy and simulations","volume":"31","author":"Dutta","year":"2018","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.ejpb.2026.115183_b0180","article-title":"Mechanisms of cisplatin\u2010induced apoptosis and of cisplatin sensitivity: potential of BIN1 to act as a potent predictor of cisplatin sensitivity in gastric cancer treatment","volume":"2012","author":"Tanida","year":"2012","journal-title":"Int. J. Surg. Oncol."},{"key":"10.1016\/j.ejpb.2026.115183_b0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11094-019-01947-8","article-title":"Design and Antitumor activity of platinum Complexes","volume":"53","author":"Kritchenkov","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejpb.2026.115183_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1197051","article-title":"Cisplatin ototoxicity mechanism and antagonistic intervention strategy: a scope review","volume":"17","author":"Li","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.750507","article-title":"Mechanisms of chemotherapy-induced neurotoxicity","volume":"13","author":"Was","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115183_b0200","doi-asserted-by":"crossref","unstructured":"C.A. Oliveira, \u00c9.A.B. Merc\u00eas, F.S. Portela, L.F.L. Malheiro, H.B.L. Silva, L.M. De Benedictis, J.M. De Benedictis, C.C.d.\u00c1.e. Silva, A.C.L. Santos, D.P. Rosa, An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management, Clinical and Experimental Nephrology 28 (2024) 711-727.","DOI":"10.1007\/s10157-024-02490-x"},{"key":"10.1016\/j.ejpb.2026.115183_b0205","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2026.115183_b0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention","volume":"226","author":"Rybak","year":"2007","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0215","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.1073\/pnas.162491399","article-title":"Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals","volume":"99","author":"Ishida","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0220","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.otc.2021.08.007","article-title":"Mechanisms of ototoxicity and otoprotection","volume":"54","author":"Steyger","year":"2021","journal-title":"Otolaryngol. Clin. North Am."},{"key":"10.1016\/j.ejpb.2026.115183_b0225","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.molmed.2019.08.002","article-title":"Cisplatin-induced ototoxicity: updates on molecular targets","volume":"25","author":"Gentilin","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejpb.2026.115183_b0230","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1523\/JNEUROSCI.1544-10.2010","article-title":"Role of the copper transporter, CTR1, in platinum-induced ototoxicity","volume":"30","author":"More","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0235","doi-asserted-by":"crossref","first-page":"12597","DOI":"10.1021\/acsami.4c20345","article-title":"Biomimetic sealing of cisplatin by cancer cell membranes to achieve nucleophile resistance and tumor targeting for improved cancer therapy","volume":"17","author":"Xia","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2026.115183_b0240","doi-asserted-by":"crossref","DOI":"10.6064\/2012\/473829","article-title":"Membrane transporters as mediators of cisplatin effects and side effects","volume":"2012","author":"Ciarimboli","year":"2012","journal-title":"Scientifica"},{"key":"10.1016\/j.ejpb.2026.115183_b0245","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.260590","article-title":"The ototoxic drug cisplatin localises to stress granules altering their dynamics and composition","author":"Martin","year":"2023","journal-title":"Journal of Cell Science 136"},{"key":"10.1016\/j.ejpb.2026.115183_b0250","article-title":"Molecular mechanisms of stress granule assembly and disassembly, Biochimica et Biophysica Acta (BBA)-Molecular","volume":"1868","author":"Hofmann","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0255","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1038\/s41401-025-01551-5","article-title":"NSCLC cells sustain phase separation of cytoplasmic membrane-less organelles to protect themselves against cisplatin treatment","volume":"46","author":"Li","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejpb.2026.115183_b0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/cancers18020260","article-title":"Stress Granule-Driven Resistance in Cancer: Mechanisms and Emerging strategies","volume":"18","author":"Rajendiran","year":"2026","journal-title":"Cancers"},{"key":"10.1016\/j.ejpb.2026.115183_b0265","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1083\/jcb.200502088","article-title":"Stress granules and processing bodies are dynamically linked sites of mRNP remodeling","volume":"169","author":"Kedersha","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2026.115183_b0270","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3389\/fphar.2020.00999","article-title":"Current strategies to combat cisplatin-induced ototoxicity","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115183_b0275","doi-asserted-by":"crossref","DOI":"10.1080\/13510002.2025.2458942","article-title":"Oxidative stress and reactive oxygen species in otorhinolaryngological diseases: insights from pathophysiology to targeted antioxidant therapies","volume":"30","author":"Meng","year":"2025","journal-title":"Redox Rep."},{"key":"10.1016\/j.ejpb.2026.115183_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2023.108783","article-title":"Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss","volume":"434","author":"Tan","year":"2023","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.heares.2013.01.006","article-title":"The mitochondrion: a perpetrator of acquired hearing loss","volume":"303","author":"B\u00f6ttger","year":"2013","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0290","article-title":"Mitochondrial dysfunction in hearing loss: oxidative stress, autophagy and NLRP3 inflammasome","volume":"11","author":"Li","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejpb.2026.115183_b0295","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1523\/JNEUROSCI.2672-20.2021","article-title":"Nox3-derived superoxide in cochleae induces sensorineural hearing loss","volume":"41","author":"Mohri","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0300","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1523\/JNEUROSCI.6054-09.2010","article-title":"Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity","volume":"30","author":"Kim","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1694131","article-title":"Mechanistic insights into cisplatin-induced ototoxicity: the central role of transient receptor potential channels","volume":"12","author":"Yu","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0310","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.heares.2004.08.002","article-title":"Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen","volume":"201","author":"Lynch","year":"2005","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0315","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3390\/antiox10121919","article-title":"Oxidative stress and inflammation caused by cisplatin ototoxicity","volume":"10","author":"Ramkumar","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2026.115183_b0320","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/00016489309135781","article-title":"Effects of free radicals on the intracellular calcium concentration in the isolated outer hair cell of the guinea pig cochlea","volume":"113","author":"Ikeda","year":"1993","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ejpb.2026.115183_b0325","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0040-1715719","article-title":"The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection","volume":"14","author":"Campbell","year":"2003","journal-title":"J. Am. Acad. Audiol."},{"key":"10.1016\/j.ejpb.2026.115183_b0330","doi-asserted-by":"crossref","first-page":"18674","DOI":"10.1074\/jbc.M111.297960","article-title":"Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4","volume":"287","author":"Jamesdaniel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2026.115183_b0335","unstructured":"M. Shahab, Role of Nitrative Stress in Cisplatin Induced Ototoxicity and Synaptic Dysfunction, Wayne State University, 2023."},{"key":"10.1016\/j.ejpb.2026.115183_b0340","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s12035-020-02226-4","article-title":"Lmo4 deficiency enhances susceptibility to cisplatin-induced cochlear apoptosis and hearing loss","volume":"58","author":"Rosati","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejpb.2026.115183_b0345","doi-asserted-by":"crossref","first-page":"12065","DOI":"10.1111\/jcmm.15839","article-title":"Inhibition of ferroptosis protects House Ear Institute\u2010Organ of Corti 1 cells and cochlear hair cells from cisplatin\u2010induced ototoxicity","volume":"24","author":"Mei","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejpb.2026.115183_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174662","article-title":"Cisplatin induces damage of auditory cells: possible relation with dynamic variation in calcium homeostasis and responding channels","volume":"914","author":"Zhao","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115183_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2022.108513","article-title":"Cisplatin exposure acutely disrupts mitochondrial bioenergetics in the zebrafish lateral-line organ","volume":"426","author":"Lee","year":"2022","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1064579","article-title":"Role and mechanism of FOXG1-related epigenetic modifications in cisplatin-induced hair cell damage","volume":"16","author":"Mu","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0365","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3390\/ijms23137227","article-title":"Pro-inflammatory signalling PRRopels cisplatin-induced toxicity","volume":"23","author":"Domingo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: at the borders of autoimmunity and inflammation","volume":"12","author":"Barnabei","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2026.115183_b0375","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051280","article-title":"Toll-like receptor 4 is activated by platinum and contributes to cisplatin-induced ototoxicity, the","volume":"22","author":"Babolmorad","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejpb.2026.115183_b0380","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/00016480701881811","article-title":"Proapoptotic effects of NF-\u03baB on cisplatin-induced cell death in auditory cell line","volume":"128","author":"Chung","year":"2008","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ejpb.2026.115183_b0385","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S0022215113000947","article-title":"Mechanisms of cisplatin ototoxicity: theoretical review","volume":"127","author":"Gon\u00e7alves","year":"2013","journal-title":"The Journal of Laryngology & Otology"},{"key":"10.1016\/j.ejpb.2026.115183_b0390","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41586-023-06742-w","article-title":"Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome","volume":"624","author":"Shi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2026.115183_b0395","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejpb.2026.115183_b0400","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22228","article-title":"Autophagy inhibition\u2010enhanced assembly of the NLRP3 inflammasome is associated with cisplatin\u2010induced acute injury to the liver and kidneys in rats","volume":"33","author":"Qu","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejpb.2026.115183_b0405","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00204-023-03544-x","article-title":"Apelin-13 protects against cisplatin-induced ototoxicity by inhibiting apoptosis and regulating STAT1 and STAT3","volume":"97","author":"Yin","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejpb.2026.115183_b0410","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1038\/cddis.2011.63","article-title":"Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation","volume":"2","author":"Kaur","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejpb.2026.115183_b0415","doi-asserted-by":"crossref","first-page":"e2019","DOI":"10.1038\/cddis.2015.362","article-title":"Loss of STAT1 protects hair cells from ototoxicity through modulation of STAT3, c-Jun","volume":"6","author":"Levano","year":"2015","journal-title":"Akt, and Autophagy Factors, Cell Death & Disease"},{"key":"10.1016\/j.ejpb.2026.115183_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125948","article-title":"Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity","volume":"14","author":"Al Aameri","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2026.115183_b0425","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.3390\/ijms24054620","article-title":"Degranulation of murine resident cochlear mast cells: a possible factor contributing to cisplatin-induced ototoxicity and neurotoxicity","volume":"24","author":"Karayay","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0430","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/antiox13121578","article-title":"Cisplatin-induced hearing loss, oxidative stress, and antioxidants as a therapeutic strategy\u2014a state-of-the-art review","volume":"13","author":"Rose","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2026.115183_b0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2006.00599.x","article-title":"Glucocorticoid modulation of cytokine signaling","volume":"68","author":"Rogatsky","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.ejpb.2026.115183_b0440","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10753-022-01714-0","article-title":"Investigation of TLR4 antagonists for prevention of intestinal inflammation","volume":"46","author":"Tam","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.ejpb.2026.115183_b0445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10753-019-01098-8","article-title":"Target of MCC950 in inhibition of NLRP3 inflammasome activation: a literature review","volume":"43","author":"Wu","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.ejpb.2026.115183_b0450","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s10787-025-01884-x","article-title":"Targeting JAK\/STAT signaling pathway by curcumin: implications for spinal cord injury neuroprotection: AA Gholami et al","volume":"33","author":"Abroumand Gholami","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejpb.2026.115183_b0455","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/MAO.0b013e31815aee21","article-title":"Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph","volume":"28","author":"Bird","year":"2007","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.ejpb.2026.115183_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120038","article-title":"Nanocarriers for drug delivery to the inner ear: Physicochemical key parameters, biodistribution, safety and efficacy","volume":"592","author":"Jaudoin","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115183_b0465","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40005-022-00586-8","article-title":"Intratympanic drug delivery systems to treat inner ear impairments","volume":"53","author":"Nguyen","year":"2023","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ejpb.2026.115183_b0470","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4155\/tde.12.130","article-title":"Drug delivery to the ear","volume":"4","author":"Hoskison","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2026.115183_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112382","article-title":"Translation inhibition and suppression of stress granules formation by cisplatin","volume":"145","author":"Pietras","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2026.115183_b0480","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.3390\/ma15113780","article-title":"Nanomaterials for inner ear diseases: challenges, limitations and opportunities","volume":"15","author":"Li","year":"2022","journal-title":"Materials"},{"key":"10.1016\/j.ejpb.2026.115183_b0485","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1080\/17435889.2025.2570706","article-title":"Nanomaterials and nanotechnology in otolaryngology: a narrative review","volume":"20","author":"Bayar Muluk","year":"2025","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115183_b0490","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.joto.2023.09.005","article-title":"Intratympanic injection of hydrogel nanodrug for the prevention and treatment of sensorineural hearing loss","volume":"18","author":"Zhai","year":"2023","journal-title":"Journal of Otology"},{"key":"10.1016\/j.ejpb.2026.115183_b0495","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2217\/nnm-2020-0198","article-title":"Development of nanoparticle drug-delivery systems for the inner ear","volume":"15","author":"An","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115183_b0500","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/pharmaceutics15071816","article-title":"Research progress on the mechanism of nanoparticles crossing the intestinal epithelial cell membrane","volume":"15","author":"He","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115183_b0505","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.3390\/ijms25137098","article-title":"Nanostructure-mediated transport of therapeutics through epithelial barriers","volume":"25","author":"Hansen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0510","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1080\/21691401.2019.1573182","article-title":"Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities","volume":"47","author":"Mittal","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115183_b0515","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3390\/ph17121741","article-title":"Sodium thiosulfate: an innovative Multi-Target repurposed treatment strategy for Late-Onset alzheimer\u2019s disease","volume":"17","author":"Hayden","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2026.115183_b0520","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nchembio.1834","article-title":"Biogenesis of reactive sulfur species for signaling by hydrogen sulfide oxidation pathways","volume":"11","author":"Mishanina","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejpb.2026.115183_b0525","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.niox.2014.10.002","article-title":"Sodium thiosulfate attenuates angiotensin II-induced hypertension, proteinuria and renal damage","volume":"42","author":"Snijder","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejpb.2026.115183_b0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124881","article-title":"Sodium thiosulfate ameliorates oxidative stress and preserves renal function in hyperoxaluric rats","volume":"10","author":"Bijarnia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2026.115183_b0535","doi-asserted-by":"crossref","unstructured":"V.S. Bebarta, M. Brittain, A. Chan, N. Garrett, D. Yoon, T. Burney, D. Mukai, M. Babin, R.B. Pilz, S.B. Mahon, Sodium nitrite and sodium thiosulfate are effective against acute cyanide poisoning when administered by intramuscular injection, Annals of emergency medicine 69 (2017) 718-725. e714.","DOI":"10.1016\/j.annemergmed.2016.09.034"},{"key":"10.1016\/j.ejpb.2026.115183_b0540","doi-asserted-by":"crossref","unstructured":"C.G. Le Prell, K. Roth, K.C. Campbell, Toward Clinical Pharmacologic Otoprotection, in: Advances in Audiology and Hearing Science (2-volume set), Apple Academic Press, 2022, pp. 751-804.","DOI":"10.1201\/9780429292668-36"},{"key":"10.1016\/j.ejpb.2026.115183_b0545","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/nep.13081","article-title":"Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients","volume":"23","author":"Peng","year":"2018","journal-title":"Nephrology"},{"key":"10.1016\/j.ejpb.2026.115183_b0550","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.3390\/ijms22126452","article-title":"Hydrogen sulfide metabolite, sodium thiosulfate: clinical applications and underlying molecular mechanisms","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0555","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/ijp.IJP_751_16","article-title":"Renal mitochondria can withstand hypoxic\/ischemic injury secondary to renal failure in uremic rats pretreated with sodium thiosulfate","volume":"49","author":"Mohan","year":"2017","journal-title":"Indian Journal of Pharmacology"},{"key":"10.1016\/j.ejpb.2026.115183_b0560","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.freeradbiomed.2023.04.012","article-title":"Sodium thiosulfate refuels the hepatic antioxidant pool reducing ischemia-reperfusion-induced liver injury","volume":"204","author":"Press","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejpb.2026.115183_b0565","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.niox.2024.06.004","article-title":"Sodium thiosulfate: a donor or carrier signaling molecule for hydrogen sulfide?","volume":"149","author":"Tang","year":"2024","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejpb.2026.115183_b0570","article-title":"Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases","volume":"1866","author":"Kruithof","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"10.1016\/j.ejpb.2026.115183_b0575","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3390\/molecules21121753","article-title":"Sulfur atom in its bound state is a unique element involved in physiological functions in mammals","volume":"21","author":"Koike","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115183_b0580","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/antiox10030373","article-title":"Fighting oxidative stress with sulfur: Hydrogen sulfide in the renal and cardiovascular systems","volume":"10","author":"Scammahorn","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2026.115183_b0585","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/ars.2011.4363","article-title":"Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice","volume":"17","author":"Tokuda","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejpb.2026.115183_b0590","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0378-5955(88)90042-1","article-title":"Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs","volume":"35","author":"Otto","year":"1988","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0595","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1200\/JCO.23.02353","article-title":"Use of sodium thiosulfate as an otoprotectant in patients with cancer treated with platinum compounds: a review of the literature","volume":"42","author":"Meijer","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2026.115183_b0600","first-page":"706","article-title":"In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity","volume":"56","author":"Neuwelt","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0605","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-5955(95)00066-D","article-title":"The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity","volume":"86","author":"Church","year":"1995","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2026.115183_b0610","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40272-022-00550-x","article-title":"Sodium thiosulfate: pediatric first approval","volume":"25","author":"Dhillon","year":"2023","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.ejpb.2026.115183_b0615","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30248","article-title":"Sodium thiosulfate as cisplatin otoprotectant in children: the challenge of when to use it","volume":"70","author":"Brock","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejpb.2026.115183_b0620","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from cisplatin-induced hearing loss","volume":"378","author":"Brock","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2026.115183_b0625","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30550","article-title":"Reevaluation of sodium thiosulfate otoprotection using the consensus International Society of Paediatric Oncology Ototoxicity Scale: a report from the Children's Oncology Group study ACCL0431","author":"Orgel","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejpb.2026.115183_b0630","first-page":"1","article-title":"The chemistry of complexes related to cis-Pt (NH3) 2Cl2. an anti-tumour drug, in","author":"Thomson","year":"2005","journal-title":"Structure and Bonding, Volume 11, Springer"},{"key":"10.1016\/j.ejpb.2026.115183_b0635","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0028-3908(03)00194-1","article-title":"Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig","volume":"45","author":"Wang","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejpb.2026.115183_b0640","doi-asserted-by":"crossref","unstructured":"S.H. Boppana, L.S. Kutikuppala, S. Sharma, M. C, G. Rangari, A.K. Misra, V. Kandi, S. Mishra, P.K. Singh, A.A. Rabaan, Current approaches in smart nano\u2010inspired drug delivery: a narrative review, Health science reports 7 (2024) e2065.","DOI":"10.1002\/hsr2.2065"},{"key":"10.1016\/j.ejpb.2026.115183_b0645","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1002\/sen2.5","article-title":"Advances in Understanding the Pathogenesis of Sensorineural Hearing loss: Treatment strategies and Implications for Auditory Protection","volume":"1","author":"Yan","year":"2025","journal-title":"Sensory Neuroscience"},{"key":"10.1016\/j.ejpb.2026.115183_b0650","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: Structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejpb.2026.115183_b0655","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejmech.2003.12.004","article-title":"The factors that influence permeation across the blood\u2013brain barrier","volume":"39","author":"Abraham","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejpb.2026.115183_b0660","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2021.12.032","article-title":"Effect of micro-and nanoparticle shape on biological processes","volume":"342","author":"Hadji","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115183_b0665","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115183_b0670","doi-asserted-by":"crossref","first-page":"14690","DOI":"10.1039\/D5TB01324K","article-title":"Rationally designed sodium thiosulfate-loaded solid lipid nanoparticles for inner ear delivery and prevention of medication-induced ototoxicity","volume":"13","author":"Chakrabarty","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2026.115183_b0675","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/antiox11112092","article-title":"Sodium thiosulphate-loaded liposomes control hydrogen sulphide release and retain its biological properties in hypoxia-like environment","volume":"11","author":"Sanchez-Aranguren","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2026.115183_b0680","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3390\/antiox13121574","article-title":"Antihypertensive effects of a sodium thiosulfate-loaded nanoparticle in a juvenile chronic kidney disease rat model","volume":"13","author":"Tain","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2026.115183_b0685","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/17458080.2022.2060963","article-title":"Novel controlled-release polylactic-co-glycolic acid (PLGA) nanoparticles for sodium thiosulphate, a hydrogen sulphide donor, retains pro-angiogenic potential of hydrogen sulphide","volume":"17","author":"Marwah","year":"2022","journal-title":"J. Exp. Nanosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0690","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijbiomac.2018.08.180","article-title":"Preparation of N-succinyl-chitin nanoparticles and their applications in otoneurological pathology","volume":"120","author":"Petrova","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115183_b0695","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11094-017-1517-3","article-title":"Conjugation of Succinate to Chitosan increases the Cochlear Cytoprotective effect","volume":"50","author":"Panevin","year":"2017","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejpb.2026.115183_b0700","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.791573","article-title":"Nanocarriers for inner ear disease therapy","volume":"15","author":"Xu","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0705","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1134\/S1063784218090207","article-title":"Porous Silicon as a Nanomaterial for Disperse Transport Systems of Targeted Drug Delivery to the inner Ear","volume":"63","author":"Spivak","year":"2018","journal-title":"Tech. Phys."},{"key":"10.1016\/j.ejpb.2026.115183_b0710","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/00016489.2015.1129069","article-title":"Superparamagnetic nanoparticles as vectors for inner ear treatments: driving and toxicity evaluation","volume":"136","author":"Nguyen","year":"2016","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ejpb.2026.115183_b0715","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/15376516.2016.1169341","article-title":"Mast cell accumulation precedes tissue fibrosis induced by intravenously administered amorphous silica nanoparticles","volume":"26","author":"Zhuravskii","year":"2016","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.ejpb.2026.115183_b0720","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.otc.2004.04.001","article-title":"The history of intratympanic drug therapy in otology","volume":"37","author":"Lustig","year":"2004","journal-title":"Otolaryngol. Clin. North Am."},{"key":"10.1016\/j.ejpb.2026.115183_b0725","first-page":"201","article-title":"Round window membrane","volume":"36","author":"Goycoolea","year":"1997","journal-title":"Structure Function and Permeability: a Review, Microscopy Research and Technique"},{"key":"10.1016\/j.ejpb.2026.115183_b0730","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1039\/C3LC51105G","article-title":"A microfluidic reciprocating intracochlear drug delivery system with reservoir and active dose control","volume":"14","author":"Kim","year":"2014","journal-title":"Lab Chip"},{"key":"10.1016\/j.ejpb.2026.115183_b0735","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/17425247.2018.1444026","article-title":"Intracochlear drug delivery systems: a novel approach whose time has come","volume":"15","author":"Peppi","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115183_b0740","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1207141","article-title":"Overcoming barriers: a review on innovations in drug delivery to the middle and inner ear","volume":"14","author":"Delaney","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115183_b0745","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpharm.2017.08.084","article-title":"Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery","volume":"532","author":"Cai","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115183_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.104086","article-title":"Improved inner ear drug delivery using hydrogel carriers","volume":"79","author":"Mfoafo","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115183_b0755","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.joto.2017.12.001","article-title":"Pharmacokinetics of sodium thiosulfate in Guinea pig perilymph following middle ear application","volume":"13","author":"Schroeder","year":"2018","journal-title":"Journal of Otology"},{"key":"10.1016\/j.ejpb.2026.115183_b0760","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/MAO.0000000000003069","article-title":"Transtympanic sodium thiosulfate for prevention of cisplatin-induced ototoxicity: a randomized clinical trial","volume":"42","author":"Duinkerken","year":"2021","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.ejpb.2026.115183_b0765","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s10637-020-00918-1","article-title":"Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients","volume":"38","author":"Viglietta","year":"2020","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.ejpb.2026.115183_b0770","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1200\/JCO.24.00905","article-title":"Randomized phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity","volume":"43","author":"Panizza","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2026.115183_b0775","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00405-020-06003-w","article-title":"Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far?","volume":"277","author":"Waissbluth","year":"2020","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.ejpb.2026.115183_b0780","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-107101","article-title":"Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial","volume":"15","author":"Burger","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejpb.2026.115183_b0785","article-title":"Tracking the Spatiotemporal Journey of Chitosan Nanoparticles across Ear Physiological Barriers: Mechanisms and Pathways","volume":"100233","author":"Wen","year":"2026","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2026.115183_b0790","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ame2.70041","article-title":"Intratympanic dexamethasone microcrystals\/lidocaine\u2010loaded PLGA non\u2010spherical microparticles for local drug delivery to the inner ear","volume":"8","author":"Wang","year":"2025","journal-title":"Anim. Models Exp. Med."},{"key":"10.1016\/j.ejpb.2026.115183_b0795","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fncel.2019.00268","article-title":"Middle ear administration of a particulate chitosan gel in an in vivo model of cisplatin ototoxicity","volume":"13","author":"Videhult Pierre","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejpb.2026.115183_b0800","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/ohn.656","article-title":"Intratympanic gels for inner ear disorders: a scoping review of clinical trials","volume":"170","author":"Brotto","year":"2024","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.ejpb.2026.115183_b0805","doi-asserted-by":"crossref","first-page":"e515","DOI":"10.1097\/MAO.0000000000004800","article-title":"Impact of pH on Intratympanic Sodium Thiosulfate-hyaluronan Gel in Preventing Cisplatin-induced Ototoxicity","author":"Pierre","year":"2026","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.ejpb.2026.115183_b0810","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.2147\/IJN.S195336","article-title":"Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity","author":"Chen","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2026.115183_b0815","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijporl.2019.04.003","article-title":"Dexamethasone-loaded chitosan-based genipin-cross-linked hydrogel for prevention of cisplatin induced ototoxicity in Guinea pig model","volume":"122","author":"Asl\u0131er","year":"2019","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.ejpb.2026.115183_b0820","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2016.02.048","article-title":"Inner ear delivery of dexamethasone using injectable silk-polyethylene glycol (PEG) hydrogel","volume":"503","author":"Yu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115183_b0825","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejpb.2020.03.005","article-title":"Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear","volume":"150","author":"Gausterer","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115183_b0830","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00280-011-1656-2","article-title":"Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model","volume":"68","author":"Berglin","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115183_b0835","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1080\/10717544.2021.1992041","article-title":"Local drug delivery using poly (lactic-co-glycolic acid) nanoparticles in thermosensitive gels for inner ear disease treatment","volume":"28","author":"Kim","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115183_b0840","article-title":"Novel self-degradable prodrug blend thermogel for intratympanic drug delivery to treat inner ear diseases","volume":"476","author":"Le","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejpb.2026.115183_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164947","article-title":"Self-degradable prodrug thermogel: a new injectable formulation for efficient and safe inner ear therapy","volume":"519","author":"Jin","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejpb.2026.115183_b0850","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03639045.2017.1373803","article-title":"A novel vehicle for local protein delivery to the inner ear: injectable and biodegradable thermosensitive hydrogel loaded with PLGA nanoparticles","volume":"44","author":"Dai","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115183_b0855","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s12951-024-02686-z","article-title":"Crosslinked-hybrid nanoparticle embedded in thermogel for sustained co-delivery to inner ear","volume":"22","author":"Thakur","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2026.115183_b0860","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002082","article-title":"Mimicking the human tympanic membrane: the significance of scaffold geometry","volume":"10","author":"Anand","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejpb.2026.115183_b0865","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4081\/audiores.2015.117","article-title":"Outlook for tissue engineering of the tympanic membrane","volume":"5","author":"Villar-Fernandez","year":"2015","journal-title":"Audiology Research"},{"key":"10.1016\/j.ejpb.2026.115183_b0870","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2018.06.019","article-title":"Synergy between chemical permeation enhancers and drug permeation across the tympanic membrane","volume":"289","author":"Yang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115183_b0875","article-title":"A Pseudo\u2010Surfactant Chemical Permeation Enhancer to Treat Otitis Media via Sustained Transtympanic delivery of Antibiotics","volume":"13","author":"Liu","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejpb.2026.115183_b0880","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-3659(99)00120-0","article-title":"Spatially constrained skin electroporation with sodium thiosulfate and urea creates transdermal microconduits","volume":"61","author":"Ilic","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115183_b0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2024.101875","article-title":"Liposomes: Bridging the gap from lab to pharmaceuticals","volume":"75","author":"Eugster","year":"2025","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0890","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2016.09.027","article-title":"Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs","volume":"514","author":"Joshi","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115183_b0895","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40005-017-0320-1","article-title":"Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles","volume":"47","author":"Son","year":"2017","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ejpb.2026.115183_b0900","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1039\/D5RA06007A","article-title":"PLGA nanoparticles in otoprotection and inner ear regeneration: a new frontier in nanomedicine for hearing disorders","volume":"16","author":"Jimoh","year":"2026","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2026.115183_b0905","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.2147\/IJN.S116867","article-title":"Nanomedicine strategy for optimizing delivery to outer hair cells by surface-modified poly (lactic\/glycolic acid) nanoparticles with hydrophilic molecules","author":"Wen","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2026.115183_b0910","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202270193","article-title":"Adhesive and injectable hydrogel microspheres for inner ear treatment","volume":"18","author":"Chen","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2026.115183_b0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113728","article-title":"Bioadhesive drug-loaded microparticles prolong drug retention in the middle ear and ameliorate cisplatin-induced hearing loss","volume":"383","author":"Zhou","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115183_b0920","doi-asserted-by":"crossref","first-page":"46212","DOI":"10.1021\/acsami.2c11647","article-title":"Microfluidic preparation of gelatin methacryloyl microgels as local drug delivery vehicles for hearing loss therapy","volume":"14","author":"Wang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2026.115183_b0925","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1021\/acs.jmedchem.7b01653","article-title":"Progress in the development of preventative drugs for cisplatin-induced hearing loss: Miniperspective","volume":"61","author":"Hazlitt","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejpb.2026.115183_b0930","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00280-011-1656-2","article-title":"Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model","volume":"68","author":"Engmer Berglin","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115183_b0935","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2012.09.032","article-title":"Penetration enhancers","volume":"64","author":"Williams","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115183_b0940","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2016.04.030","article-title":"Chemical penetration enhancers in stratum corneum\u2014Relation between molecular effects and barrier function","volume":"232","author":"Pham","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115183_b0945","article-title":"Comparing round window membrane permeability enhancers: an animal study","volume":"107256","author":"Han","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115183_b0950","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.3390\/ijms221810061","article-title":"Junctional modulation of round window membrane enhances dexamethasone uptake into the inner ear and recovery after NIHL","volume":"22","author":"Jeong","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:14:06Z","timestamp":1788174846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":190,"alternative-id":["S0939641126002043"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115183","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced delivery systems for sodium thiosulfate in cisplatin otoprotection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115183"}}